SNYR (Synergy CHC) EBIT per Share: $-0.68 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Synergy CHC EBIT per Share?

Synergy CHC SNYR +34.66% EBIT per Share is $-0.68 as of Mar. 2026. The stock has 3 warning signs investors should review. Among 105 Medical Distribution companies, Synergy CHC ranks worse than 952380% on this metric.

Synergy CHC's EBIT per Share for the three months ended in Mar. 2026 was $-0.05. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.68.

During the past 12 months, the average EBIT per Share Growth Rate of Synergy CHC was -144.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Synergy CHC's EBIT per Share or its related term are showing as below:

During the past 11 years, the highest 3-Year average EBIT per Share Growth Rate of Synergy CHC was 82.00% per year. The lowest was -28.70% per year. And the median was 26.65% per year.

SNYR's 3-Year EBIT Growth Rate is not ranked *
in the Medical Distribution industry.
Industry Median: 2.7
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Synergy CHC's EBIT for the three months ended in Mar. 2026 was $-0.57 Mil.

Synergy CHC  (NAS:SNYR) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Synergy CHC EBIT per Share Related Terms

Synergy CHC EBIT per Share Historical Data

* Premium members only.

The historical data trend for Synergy CHC's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synergy CHC EBIT per Share Chart

Synergy CHC Annual Data
Trend Jul13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec23 Dec24 Dec25
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.70 -1.07 1.47 0.83 -0.65

Synergy CHC Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.42 0.13 -1.18 -0.05

Synergy CHC EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Synergy CHC's EBIT per Share for the fiscal year that ended in Dec. 2025 is calculated as

EBIT per Share(A: Dec. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-6.304/9.723
=-0.65

Synergy CHC's EBIT per Share for the quarter that ended in Mar. 2026 is calculated as

EBIT per Share(Q: Mar. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.57/11.304
=-0.05

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $-0.68 mean?
Synergy CHC (SNYR) has a EBIT per Share of $-0.68 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Synergy CHC and its competitors. According to the industry distribution chart, Synergy CHC ranks #999999 out of 105 companies in the Medical Distribution industry.
Is Synergy CHC's EBIT per Share too high?
Synergy CHC's current EBIT per Share is $-0.68. Based on the distribution chart, Synergy CHC ranks #999999 out of 105 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers.
How does Synergy CHC's EBIT per Share compare to MEDS and MCK?
According to the Medical Distribution industry distribution chart, Synergy CHC ranks #999999 out of 105 companies for EBIT per Share. This places Synergy CHC in the lower half of its industry. The industry median EBIT per Share is 2.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Distribution company?
The median EBIT per Share among Medical Distribution companies is 2.70, based on 105 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Synergy CHC and its competitors. For the Medical Distribution industry, the median EBIT per Share is 2.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synergy CHC's current EBIT per Share is $-0.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synergy CHC stock overvalued right now?
Based on GuruFocus' analysis, Synergy CHC (SNYR) is currently considered Possible Value Trap. The stock's GF Value™ is $1.08, compared to a current price of $0.11 — trading 90% below its estimated fair value. The current EBIT per Share is $-0.68. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Synergy CHC (SNYR), the current EBIT per Share is $-0.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Synergy CHC Business Description

Address 1016, 770 Roosevelt Trail, Suite 8, North Windham, ME, USA, 04062
Synergy CHC Corp is a provider of consumer health care, beauty, and lifestyle products. It is engaged in the business of marketing and distributing consumer-branded products through various distribution channels in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen, amongst others. Flat Tummy is a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight management goals.